Former Executive Director

Chih-Cheng Hsu, M.D. , Dr. P.H.

POSITION:
  • Executive Director, National Health Research Institutes Forum ( 2019.11.01~2022.02.28 )
  • Investigator and Deputy Director
    Institute of Population Health Sciences, National Health Research Institutes
  • Honorary Investigator
    Department of Health Services Administration, China Medical University
  • Adjunct Professor
    Institute of Clinical Medicine, National Yang-Ming University
EDUCATION:
  • Doctor of Public Health, Tulane University, U.S.A. (2000)
  • Doctor of Medicine, National Yang-Ming University, Taiwan (1986 )
  • Master of Public Health, National Taiwan University, Taiwan (1992)
PROFESSIONAL EXPERIENCES:
  • Investigator and Deputy Director (August 2014-present)
    Institute of Population Health Sciences, National Health Research
    Institutes, Taiwan
  • Division of Geriatrics and Gerontology (2011-2014)
    Institute of Population Health Sciences, National Health Research
    Institutes, Taiwan
    Associate Investigator and Director
  • Adjunct Professor (2015-present)
    Institute of Clinical Medicine, National Yang-Ming University, Taiwan
  • Associate Investigator (June 2006- July 2014)
    Institute of Population Health Sciences, National Health Research
    Institutes, Taiwan
  • Assistant Investigator (2001- May 2006)
    Division of Health Policy Research, National Health Research
    Institutes, Taiwan

RESEARCH INTERESTS:

Geriatric Research, Epidemiology and care of diabetes mellitus, Epidemiology and prevention of chronic kidney diseases, Program evaluation, Tobacco control

RESEARCH ACITIVITIES & ACCOMPLISHMENT:

Over 150 SCI papers (since 2000) in chronic kidney disease, diabetes, tobacco control, and geriatric research
National Health Research Institutes-Institutional Repository:
http://211.76.174.198/handle/3990099045/7501

Shih-Feng Tsai, M.D. Ph. D.

POSITION:
  • Executive Director,  National Health Research Institutes Forum ( 2013.11 ~ 2019.11.30 )
  • Distinguished Investigator, Institute of Molecular and Genomic Medicine
  • Associate professor, Department of Life Sciences and Institute Genome Sciences /  Institute of Clinical Medicine, National Yang Ming Chiao Tung University
  • Associate professor, Department of Life Sciences, National Tsing Hua University
  • Director, The Taiwan Society for Biochemistry and Molecular Biology
EDUCATION:
  • Ph.D., Division of Human Genetics, Mt. Sinai School of Medicine, City University of New York, USA (1987)
  • M.D., Taipei Medical College, Taiwan (1981)
PROFESSIONAL EXPERIENCES:

  • Distinguished Investigator Institute of Molecular and Genomic Medicine (Previously Division of Molecular and Genomic Medicine), National Health Research Institutes, Taiwan (2010- present)

  • Professor National Tsing Hua University, Taiwan (2007- present)

  • Director Division of Molecular and Genomic Medicine, National Health Research Institutes, Taiwan (2000- 2007)

  • Investigator Division of Molecular and Genomic Medicine, National Health Research Institutes, Taiwan (2000- 2010)

  • Professor Institute of Genome Sciences (Previously Institute of Genetics), National Yang-Ming University, Taiwan (1997-present)

  • Associate Professor Institute of Genetics, National Yang-Ming University, Taiwan (1991-1997)

  • Fellow Department of Pediatrics, Harvard Medical School, USA (1988-1990)

  • Fellow Division of Hematology/Oncology, Children’s Hospital, Boston, USA (1988-1990)

  • Fellow Division of Medical Genetics, Mt. Sinai Medical Center, New York, USA (1987-1988)

RESEARCH INTERESTS:

Prof. Tsai’s research areas include human genetics, cancer genomics, and microbial genomics. His laboratory has applied genetic mapping and genomic technology to identifying genes associated with human diseases. Using high-throughput genotyping and DNA sequencing, recently, his laboratory has succeeded in discovering the genes responsible for two inherited diseases: type II collagen in osteonecrosis and IL6 receptor family genes in primary cutaneous amyloidosis. Also, he has characterized the genomic alterations associated with lung cancer and liver cancer and investigated the genetic basis determining individual difference in cancer treatment response. In the microbial genomics field, Professor Tsai is a world expert on several important pathogenic bacteria, including V. vulnificus, K. pneumoniae, A. baumannii, and M. tuberculosis, all of which pose threats to health globally.